New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results